As a result, the liposome platform holds tremendous promise in the future of targeted cancer therapeutics to improve drug delivery while minimizing unwanted systemic bystander effects. This review ...

Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the ...

be used to carry anti-TB drugs. Many of the formulations presented are very similar to others that reach the market with regard to the size of the liposome and its constitution. However ...

CNW/ -- (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and ...

Israel: Innocan Pharma Corporation has announced that it has been granted a patent in India covering a prolonged-release ...

Randomized trial of liposomal bupivacaine for hip fracture surgery Liposomal bupivacaine is a long-acting local anesthetic developed for use in relieving postoperative pain, allowing drug release ...

India has developed a novel antibiotic to fight antimicrobial resistance (AMR), as well as a new drug to tackle burden of ...

A scientist in a lab coat mixing the chemicals for the Liposomal Bcl-2 drug development. Turning to the performance of the ...

liposome properties, such as size, surface charge and functionality, can be easily tuned. Polymeric nanocarriers can be categorized based on three drug-incorporation mechanisms. The first includes ...

Randomized trial of liposomal bupivacaine for hip fracture surgery Liposomal bupivacaine is a long-acting local anesthetic ...

Alkem launches Kojiglo serum in India to manage facial hyperpigmentation: Our Bureau, Mumbai Wednesday, February 5, 2025, 12:40 Hrs [IST] Alkem Laboratories Ltd has announced the ...